CTOs on the Move

Walgreens Boots Alliance

www.walgreensbootsalliance.com

 
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise. The company`s heritage of trusted health care services through community pharmacy care and pharmaceutical wholesaling dates back more than 100 years. Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25* countries and employ more than 385,000* people. The company is a global leader in pharmacy-led, health and wellbeing retail and, together with the companies in which ...
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Vish Sankaran
Global Chief Innovation Officer Profile
Alejandro Martinez-Galindo
Senior Vice President of Global Information Technology Transformation and Digital and Information Technology Shared Services Profile
John Rivera
Director Information Security Engineering Profile
Nathan Chandler
Global Director, Cyber Threat Detection and Response Profile
Mike Maresca
Global Chief Technology Officer Profile

Similar Companies

Sagimet

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors.

CALIBER THERAPEUTICS

CALIBER THERAPEUTICS is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PanTheryx

PanTheryx, Inc., a U.S. medical nutrition company based in Boulder, Colorado, is dedicated to improving global health and quality of life through innovative science.

Reata Pharmaceuticals

Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes.